The insulin pens, syringes, pumps and injectors market size has grown rapidly in recent years. It will grow from $23.52 billion in 2025 to $26.14 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of diabetes, increasing use of insulin therapy, expansion of homecare treatment models, availability of disposable insulin delivery devices, growth in patient self-management.
The insulin pens, syringes, pumps and injectors market size is expected to see rapid growth in the next few years. It will grow to $40.45 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing adoption of connected diabetes devices, rising focus on automated insulin delivery, expansion of digital diabetes management platforms, growing investments in wearable insulin technologies, increasing demand for minimally invasive delivery systems. Major trends in the forecast period include increasing adoption of smart insulin delivery devices, rising use of patch and tubeless pumps, growing demand for home-based diabetes management, expansion of connected insulin monitoring systems, enhanced focus on patient convenience.
The growing prevalence of diabetes worldwide is driving the expansion of the insulin pens, syringes, pumps, and injectors market. Diabetes is a chronic condition where the body is unable to regulate blood sugar due to insufficient insulin production or ineffective use of insulin, leading to elevated blood sugar levels. The rise in diabetes cases is primarily attributed to increasingly sedentary lifestyles and the widespread consumption of high-calorie, unhealthy diets rich in sugars and fats, which contribute to obesity and insulin resistance. As more individuals are diagnosed with diabetes, the demand for insulin delivery devices - such as pens, syringes, pumps, and injectors - continues to grow, as these devices offer effective and convenient treatment. For example, in April 2025, the International Diabetes Federation, a Belgium-based organization representing over 240 national diabetes associations, reported that China had a total adult population of approximately 1.07 billion, with 11.9% of adults affected by diabetes. This equates to around 148 million cases of diabetes in adults. As such, the increase in diabetes prevalence globally is significantly driving the growth of the insulin delivery devices market.
Many companies operating in the insulin pens, syringes, pumps, and injectors market are focusing on technological advancements in insulin delivery systems to ensure effective and safe insulin administration. Insulin delivery systems are tools designed to provide insulin to diabetic patients, including devices such as pens, syringes, pumps, and injectors, ensuring precise and efficient blood sugar management. For instance, in June 2024, Insulet Corporation, a US-based medical equipment manufacturing company, launched the Omnipod 5, a tubeless automated insulin delivery system for individuals with type 1 diabetes aged two and older. It is the first system to integrate with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitors, offering unique compatibility with these leading CGM brands for enhanced diabetes management.
In September 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Bigfoot Biomedical Inc. for an undisclosed sum. This acquisition is part of Abbott's strategy to expand its presence in diabetes care and strengthen its portfolio of connected diabetes solutions. Bigfoot Biomedical Inc. is a US medical technology company specializing in the development and manufacturing of diabetes management systems, including insulin pens and syringes.
Major companies operating in the insulin pens, syringes, pumps and injectors market are Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.
North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2025. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the insulin pens, syringes, pumps and injectors market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the insulin pens, syringes, pumps, and injectors market by increasing costs of imported plastics, electronic components, micro-needles, and precision molding equipment. North America and Europe are most affected due to reliance on global component sourcing, while Asia-Pacific faces pricing pressure on device exports. These tariffs are increasing device prices and affecting affordability for patients. However, they are also encouraging local manufacturing, regional assembly of insulin devices, and innovation in cost-effective delivery solutions.
The insulin pens, syringes, pumps and injectors market research report is one of a series of new reports that provides insulin pens, syringes, pumps and injectors market statistics, including insulin pens, syringes, pumps and injectors industry global market size, regional shares, competitors with a insulin pens, syringes, pumps and injectors market share, detailed insulin pens, syringes, pumps and injectors market segments, market trends and opportunities, and any further data you may need to thrive in the insulin pens, syringes, pumps and injectors industry. This insulin pens, syringes, pumps and injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Insulin pens, syringes, pumps, and injectors play a crucial role in regulating the blood glucose levels of diabetic individuals. These tools can be either reusable or disposable and are employed for the purpose of delivering the required insulin dosage into the bloodstream of diabetic patients.
The primary categories of insulin delivery devices and equipment encompass pens, injectors, pumps, and syringes. A syringe serves as an instrument for introducing or extracting fluids. Both reusable and disposable pens are utilized for insulin administration. Pumps are available in two forms, including tube pumps and tubeless pumps. These devices find applications in a variety of settings, such as hospitals, home care, and others.
The insulin pens, syringes, pumps, and injectors market consist of sales of reusable pens, disposable pens, tubed pumps, and tubeless pumps that are used for injecting insulin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The insulin pens, syringes, pumps and injectors market size is expected to see rapid growth in the next few years. It will grow to $40.45 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing adoption of connected diabetes devices, rising focus on automated insulin delivery, expansion of digital diabetes management platforms, growing investments in wearable insulin technologies, increasing demand for minimally invasive delivery systems. Major trends in the forecast period include increasing adoption of smart insulin delivery devices, rising use of patch and tubeless pumps, growing demand for home-based diabetes management, expansion of connected insulin monitoring systems, enhanced focus on patient convenience.
The growing prevalence of diabetes worldwide is driving the expansion of the insulin pens, syringes, pumps, and injectors market. Diabetes is a chronic condition where the body is unable to regulate blood sugar due to insufficient insulin production or ineffective use of insulin, leading to elevated blood sugar levels. The rise in diabetes cases is primarily attributed to increasingly sedentary lifestyles and the widespread consumption of high-calorie, unhealthy diets rich in sugars and fats, which contribute to obesity and insulin resistance. As more individuals are diagnosed with diabetes, the demand for insulin delivery devices - such as pens, syringes, pumps, and injectors - continues to grow, as these devices offer effective and convenient treatment. For example, in April 2025, the International Diabetes Federation, a Belgium-based organization representing over 240 national diabetes associations, reported that China had a total adult population of approximately 1.07 billion, with 11.9% of adults affected by diabetes. This equates to around 148 million cases of diabetes in adults. As such, the increase in diabetes prevalence globally is significantly driving the growth of the insulin delivery devices market.
Many companies operating in the insulin pens, syringes, pumps, and injectors market are focusing on technological advancements in insulin delivery systems to ensure effective and safe insulin administration. Insulin delivery systems are tools designed to provide insulin to diabetic patients, including devices such as pens, syringes, pumps, and injectors, ensuring precise and efficient blood sugar management. For instance, in June 2024, Insulet Corporation, a US-based medical equipment manufacturing company, launched the Omnipod 5, a tubeless automated insulin delivery system for individuals with type 1 diabetes aged two and older. It is the first system to integrate with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitors, offering unique compatibility with these leading CGM brands for enhanced diabetes management.
In September 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Bigfoot Biomedical Inc. for an undisclosed sum. This acquisition is part of Abbott's strategy to expand its presence in diabetes care and strengthen its portfolio of connected diabetes solutions. Bigfoot Biomedical Inc. is a US medical technology company specializing in the development and manufacturing of diabetes management systems, including insulin pens and syringes.
Major companies operating in the insulin pens, syringes, pumps and injectors market are Novo Nordisk A/S, Eli Lilly and Company, Medtronic plc, Abbott Laboratories, Insulet Corporation, Sanofi Aventis, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Animas Corporation, Ypsomed Holding AG, Dickinson and Company, Valeritas Inc., MannKind Corporation, Tandem Diabetes Care Inc., Biocon Ltd., B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Nipro Corporation, Smiths Medical Inc., Owen Mumford, UltiMed Inc., Ypsomed Holding, Ascensia Diabetes Care, Trividia Health, ARKRAY Inc., AgaMatrix Inc., Medline Industries LP, Gerresheimer AG, West Pharmaceutical Services Inc., SHL Medical AG, Zhejiang POCTech Medical Co.Ltd., Jiangsu Wanhai Medical Instruments Co. Ltd.
North America was the largest region in the global insulin pens, syringes, pumps, and injectors devices and equipment market in 2025. Asia-Pacific was the second-largest region in insulin pens, syringes, pumps, and injectors devices and equipment market. The regions covered in the insulin pens, syringes, pumps and injectors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the insulin pens, syringes, pumps and injectors market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the insulin pens, syringes, pumps, and injectors market by increasing costs of imported plastics, electronic components, micro-needles, and precision molding equipment. North America and Europe are most affected due to reliance on global component sourcing, while Asia-Pacific faces pricing pressure on device exports. These tariffs are increasing device prices and affecting affordability for patients. However, they are also encouraging local manufacturing, regional assembly of insulin devices, and innovation in cost-effective delivery solutions.
The insulin pens, syringes, pumps and injectors market research report is one of a series of new reports that provides insulin pens, syringes, pumps and injectors market statistics, including insulin pens, syringes, pumps and injectors industry global market size, regional shares, competitors with a insulin pens, syringes, pumps and injectors market share, detailed insulin pens, syringes, pumps and injectors market segments, market trends and opportunities, and any further data you may need to thrive in the insulin pens, syringes, pumps and injectors industry. This insulin pens, syringes, pumps and injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Insulin pens, syringes, pumps, and injectors play a crucial role in regulating the blood glucose levels of diabetic individuals. These tools can be either reusable or disposable and are employed for the purpose of delivering the required insulin dosage into the bloodstream of diabetic patients.
The primary categories of insulin delivery devices and equipment encompass pens, injectors, pumps, and syringes. A syringe serves as an instrument for introducing or extracting fluids. Both reusable and disposable pens are utilized for insulin administration. Pumps are available in two forms, including tube pumps and tubeless pumps. These devices find applications in a variety of settings, such as hospitals, home care, and others.
The insulin pens, syringes, pumps, and injectors market consist of sales of reusable pens, disposable pens, tubed pumps, and tubeless pumps that are used for injecting insulin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Insulin Pens, Syringes, Pumps and Injectors Market Characteristics
3. Insulin Pens, Syringes, Pumps and Injectors Market Supply Chain Analysis
4. Global Insulin Pens, Syringes, Pumps and Injectors Market Trends and Strategies
5. Insulin Pens, Syringes, Pumps and Injectors Market Analysis of End Use Industries
7. Global Insulin Pens, Syringes, Pumps and Injectors Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Insulin Pens, Syringes, Pumps and Injectors Total Addressable Market (TAM) Analysis for the Market
9. Insulin Pens, Syringes, Pumps and Injectors Market Segmentation
10. Insulin Pens, Syringes, Pumps and Injectors Market Regional and Country Analysis
11. Asia-Pacific Insulin Pens, Syringes, Pumps and Injectors Market
12. China Insulin Pens, Syringes, Pumps and Injectors Market
13. India Insulin Pens, Syringes, Pumps and Injectors Market
14. Japan Insulin Pens, Syringes, Pumps and Injectors Market
15. Australia Insulin Pens, Syringes, Pumps and Injectors Market
16. Indonesia Insulin Pens, Syringes, Pumps and Injectors Market
17. South Korea Insulin Pens, Syringes, Pumps and Injectors Market
18. Bangladesh Insulin Pens, Syringes, Pumps and Injectors Market
19. Thailand Insulin Pens, Syringes, Pumps and Injectors Market
20. Vietnam Insulin Pens, Syringes, Pumps and Injectors Market
21. Malaysia Insulin Pens, Syringes, Pumps and Injectors Market
22. Singapore Insulin Pens, Syringes, Pumps and Injectors Market
23. Philippines Insulin Pens, Syringes, Pumps and Injectors Market
24. Hong Kong Insulin Pens, Syringes, Pumps and Injectors Market
25. New Zealand Insulin Pens, Syringes, Pumps and Injectors Market
26. Taiwan Insulin Pens, Syringes, Pumps and Injectors Market
27. South East Asia Insulin Pens, Syringes, Pumps and Injectors Market
28. Western Europe Insulin Pens, Syringes, Pumps and Injectors Market
29. UK Insulin Pens, Syringes, Pumps and Injectors Market
30. Germany Insulin Pens, Syringes, Pumps and Injectors Market
31. France Insulin Pens, Syringes, Pumps and Injectors Market
32. Italy Insulin Pens, Syringes, Pumps and Injectors Market
33. Spain Insulin Pens, Syringes, Pumps and Injectors Market
34. Austria Insulin Pens, Syringes, Pumps and Injectors Market
35. Belgium Insulin Pens, Syringes, Pumps and Injectors Market
36. Denmark Insulin Pens, Syringes, Pumps and Injectors Market
37. Finland Insulin Pens, Syringes, Pumps and Injectors Market
38. Ireland Insulin Pens, Syringes, Pumps and Injectors Market
39. Netherlands Insulin Pens, Syringes, Pumps and Injectors Market
40. Norway Insulin Pens, Syringes, Pumps and Injectors Market
41. Portugal Insulin Pens, Syringes, Pumps and Injectors Market
42. Sweden Insulin Pens, Syringes, Pumps and Injectors Market
42. Switzerland Insulin Pens, Syringes, Pumps and Injectors Market
43. Eastern Europe Insulin Pens, Syringes, Pumps and Injectors Market
44. Russia Insulin Pens, Syringes, Pumps and Injectors Market
45. Czech Republic Insulin Pens, Syringes, Pumps and Injectors Market
46. Poland Insulin Pens, Syringes, Pumps and Injectors Market
47. Romania Insulin Pens, Syringes, Pumps and Injectors Market
48. Ukraine Insulin Pens, Syringes, Pumps and Injectors Market
49. North America Insulin Pens, Syringes, Pumps and Injectors Market
50. USA Insulin Pens, Syringes, Pumps and Injectors Market
51. Canada Insulin Pens, Syringes, Pumps and Injectors Market
52. Mexico Insulin Pens, Syringes, Pumps and Injectors Market
53. South America Insulin Pens, Syringes, Pumps and Injectors Market
54. Brazil Insulin Pens, Syringes, Pumps and Injectors Market
55. Chile Insulin Pens, Syringes, Pumps and Injectors Market
56. Argentina Insulin Pens, Syringes, Pumps and Injectors Market
57. Colombia Insulin Pens, Syringes, Pumps and Injectors Market
58. Peru Insulin Pens, Syringes, Pumps and Injectors Market
59. Middle East Insulin Pens, Syringes, Pumps and Injectors Market
60. Saudi Arabia Insulin Pens, Syringes, Pumps and Injectors Market
61. Israel Insulin Pens, Syringes, Pumps and Injectors Market
62. Iran Insulin Pens, Syringes, Pumps and Injectors Market
63. Turkey Insulin Pens, Syringes, Pumps and Injectors Market
64. United Arab Emirates Insulin Pens, Syringes, Pumps and Injectors Market
65. Africa Insulin Pens, Syringes, Pumps and Injectors Market
66. Egypt Insulin Pens, Syringes, Pumps and Injectors Market
67. Nigeria Insulin Pens, Syringes, Pumps and Injectors Market
68. South Africa Insulin Pens, Syringes, Pumps and Injectors Market
70. Insulin Pens, Syringes, Pumps and Injectors Market Competitive Landscape and Company Profiles
71. Insulin Pens, Syringes, Pumps and Injectors Market Other Major and Innovative Companies
74. Insulin Pens, Syringes, Pumps and Injectors Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Insulin Pens, Syringes, Pumps And Injectors Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses insulin pens, syringes, pumps and injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for insulin pens, syringes, pumps and injectors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insulin pens, syringes, pumps and injectors market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Pens; Injectors And Pumps; Syringes2) By Pens: Reusable; Disposable
3) By Pumps: Tubed Pumps; Tubeless Pumps
4) By End Users: Hospitals; Homecare; Other End Users
Subsegments:
1) By Pens: Disposable Insulin Pens; Reusable Insulin Pens2) By Injectors And Pumps: Insulin Injectors; Insulin Pumps; Traditional Insulin Pumps; Patch Insulin Pumps
3) By Syringes: Disposable Syringes; Reusable Syringes
Companies Mentioned: Novo Nordisk A/S; Eli Lilly and Company; Medtronic plc; Abbott Laboratories; Insulet Corporation; Sanofi Aventis; F. Hoffmann-La Roche Ltd; Becton Dickinson and Company; Animas Corporation; Ypsomed Holding AG; Dickinson and Company; Valeritas Inc.; MannKind Corporation; Tandem Diabetes Care Inc.; Biocon Ltd.; B. Braun Melsungen AG; Terumo Corporation; Teleflex Incorporated; Nipro Corporation; Smiths Medical Inc.; Owen Mumford; UltiMed Inc.; Ypsomed Holding; Ascensia Diabetes Care; Trividia Health; ARKRAY Inc.; AgaMatrix Inc.; Medline Industries LP; Gerresheimer AG; West Pharmaceutical Services Inc.; SHL Medical AG; Zhejiang POCTech Medical Co.Ltd.; Jiangsu Wanhai Medical Instruments Co. Ltd.
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Insulin Pens, Syringes, Pumps and Injectors market report include:- Novo Nordisk A/S
- Eli Lilly and Company
- Medtronic plc
- Abbott Laboratories
- Insulet Corporation
- Sanofi Aventis
- F. Hoffmann-La Roche Ltd
- Becton Dickinson and Company
- Animas Corporation
- Ypsomed Holding AG
- Dickinson and Company
- Valeritas Inc.
- MannKind Corporation
- Tandem Diabetes Care Inc.
- Biocon Ltd.
- B. Braun Melsungen AG
- Terumo Corporation
- Teleflex Incorporated
- Nipro Corporation
- Smiths Medical Inc.
- Owen Mumford
- UltiMed Inc.
- Ypsomed Holding
- Ascensia Diabetes Care
- Trividia Health
- ARKRAY Inc.
- AgaMatrix Inc.
- Medline Industries LP
- Gerresheimer AG
- West Pharmaceutical Services Inc.
- SHL Medical AG
- Zhejiang POCTech Medical Co.Ltd.
- Jiangsu Wanhai Medical Instruments Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 26.14 Billion |
| Forecasted Market Value ( USD | $ 40.45 Billion |
| Compound Annual Growth Rate | 11.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
